Ciprofloxacin in endophthalmitis: an emerging alternative.
Vedantham
Vasumathy
V
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002442:Ceftazidime / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D009877:Endophthalmitis / Q000188:drug therapy* / Q000382:microbiology; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D014640:Vancomycin / Q000627:therapeutic use
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D014640:Vancomycin; D002442:Ceftazidime